Day: June 15, 2023

Nokia CorporationStock Exchange Release15 June 2023 at 21:00 EEST Nokia Corporation: Repurchase of own shares on 15.06.2023 Espoo, Finland – On 15 June 2023 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows:Trading venue (MIC Code) Number of shares Weighted average price / share, EUR*XHEL 327,483 3.88CEUX 21,823 3.88AQEU 9,726 3.88TQEX 3,968 3.88Total 363,000 3.88* Rounded to two decimals On 3 February 2022, Nokia announced that its Board of Directors is initiating a share buyback program under the authorization granted by Nokia’s Annual General Meeting on 8 April 2021 to return up to EUR 600 million of cash to shareholders in tranches over a period of two years. The second phase of the share buyback program in compliance with the Market Abuse Regulation (EU) 596/2014...

The main condition of the ongoing tender offer for 100 percent of the shares in Alumetal has been fulfilled, as the existing shareholders have subscribed for the sale of at least 50 percent of the shares. As of 16:30 (CET) on Thursday, June 15, 2023, approximately 68 percent of the shares have already been subscribed. Hydro is offering PLN 82.00 per each Alumetal share to all shareholders who subscribe for the sale of shares by 23:59 on June 15, 2023. This is with the exception that approximately 32.7 percent of the shares owned by IPO30 UNIPESSOAL LDA will be acquired by Hydro at PLN 78.69 per share. As of June 16, the offer price will be reduced to the initial level, i.e. PLN 78.69 per share. Subscriptions for the sale of shares in the tender offer will be accepted until June 30, 2023. Hydro received unconditional approval from the European...

VANCOUVER, British Columbia, June 15, 2023 (GLOBE NEWSWIRE) — Orezone Gold Corporation (TSX: ORE, OTCQX: ORZCF) (the “Company” or “Orezone”) reports that all resolutions at the Company’s annual general meeting of shareholders held on June 15, 2023 were approved by shareholders with 59.22% of the total issued and outstanding shares voted. Michael Halvorson, Chairman of Orezone stated “On behalf of the Company and the board I would like to welcome Mr. Quinlan as a board member.  Mr. Quinlan is an independent nominee of Resource Capital Fund VII L.P. and has over 25 years of experience in the capital markets and mining industries.  Mr. Quinlan replaces Mr. Axcell who did not stand for re-election at the AGM. The Company would like to thank Mr. Axcell for his many contributions and guidance during his tenure as a board member. ...

Overlook at Brier Creek by Toll Brothers Toll Brothers announced its newest luxury home community, Overlook at Brier Creek in Raleigh, North Carolina.RALEIGH, N.C., June 15, 2023 (GLOBE NEWSWIRE) — Toll Brothers, Inc. (NYSE: TOL), the nation’s leading builder of luxury homes, announced a new collection of 46 home sites is coming soon to the Brier Creek Country Club community located near Globe Road in Raleigh, North Carolina. The company’s new luxury home community, Overlook at Brier Creek, will open for sales in the summer of 2023. Overlook at Brier Creek offers townhome-style condominiums with open, modern floor plans and ample storage space to meet the needs of every lifestyle. Select residences feature expansive, covered rooftop terraces with sweeping views of Brier Creek and downtown Raleigh. Residents will enjoy low-maintenance...

Leuven, BELGIUM, Boston, MA, US – June 15, 2023 – 7 pm CET – Oxurion NV (Euronext Brussels: OXUR) a biopharmaceutical company developing next-generation standard of care ophthalmic therapies, with clinical stage assets in vascular retinal disorders, has announced the completion of Tranche 3 of funding under the Subscription Agreement with Atlas Special Opportunities LLC (“Atlas”). On June 15, 2023, the Company issued 40 convertible bonds to Atlas totaling EUR one million. Under the terms of the Subscription Agreement, Atlas has committed to subscribe to up to EUR 20.8 million in mandatorily convertible bonds over a 24-month period, of which it has now subscribed to EUR 7.8 million. The conversion price is set at an eight percent discount to the average VWAP over the three lowest days in the ten consecutive trading days prior to...

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR DISSEMINATION IN UNITED STATES CALGARY, Alberta, June 15, 2023 (GLOBE NEWSWIRE) — Pieridae Energy Limited (“Pieridae”, “PEL”, or the “Company”) (TSX: PEA) is pleased to announce that its wholly-owned subsidiary Pieridae Alberta Production Ltd. (“PAPL” or the “Borrower”) has successfully completed a debt refinancing transaction, resulting in new credit facilities with Prudential Private Capital (“Prudential”) and Voya Investment Management (“Voya”) (together, the “Noteholders”), totaling USD $150 million (the “Financing”). The Financing retires Pieridae’s existing debt in advance of its upcoming maturity and materially reduces the Company’s cost of capital while providing significant flexibility and liquidity to enable execution of the Company’s strategic objectives. The...

THE INFORMATION CONTAINED HEREIN IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO AUSTRALIA, CANADA, ITALY, DENMARK, JAPAN, THE UNITED STATES, OR TO ANY NATIONAL OF SUCH JURISDICTIONS 15 June 2023 NB Private Equity Partners Limited (the “Company”) is pleased to announce that at the Annual General Meeting of its Class A Shareholders held at 1.45 p.m. on 15 June 2023, each of the Resolutions tabled were duly passed without amendment. The details of each resolution are as follows: ORDINARY RESOLUTIONS Resolution 1 THAT the Audited Financial Statements, the Directors’ report, and the auditors’ report for the financial year ended 31 December 2022 be received and considered.For (including discretionary) 22,010,759 votesAgainst    0 votesWithheld 309 votesResolution 2 THAT the Directors’ Remuneration Report as set out...

Vivoryon Therapeutics N.V. Announces CEO Transition Plan  Dr. Ulrich Dauer not to extend current term running through 2024 AGM Board to initiate succession planning  Halle (Saale) / Munich, Germany, June 15, 2023 – Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY; NL00150002Q7) (Vivoryon), a clinical stage company focused on the discovery and development of small molecule medicines to modulate the activity and stability of pathologically altered proteins, today announced that the Company’s CEO Dr. Ulrich Dauer has informed Vivoryon’s Board of Directors that he has decided not to renew his contract as a member of the Company’s executive leadership team. As a result of his decision, Dr. Dauer will step down as CEO on expiry of his current contract on the date of the 2024 Annual General Meeting or when the appointment of a suitable...